| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $104.1M | — | +3.7% |
| Cost of Revenue | $67.9M | — | +7.0% |
| Gross Profit | $36.2M | — | -2.1% |
| R&D Expense | $6.1M | — | -6.3% |
| SG&A Expense | $26.1M | — | +7.6% |
| Operating Income | -$3.7M | — | -80.7% |
| Pre-tax Income | -$440K | — | -117.8% |
| Income Tax | $1.0M | — | +333.2% |
| Net Income | -$1.5M | — | -150.6% |
| EPS (Basic) | -$0.02 | — | -166.7% |
| EPS (Diluted) | -$0.02 | — | -166.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $327.5M | -4.3% | +0.6% |
| Accounts Receivable | $87.4M | +10.0% | +7.0% |
| Current Assets | $432.2M | -1.7% | +2.5% |
| Total Assets | $605.0M | -1.3% | +2.4% |
| Current Liabilities | $54.9M | +5.3% | -5.7% |
| Total Liabilities | $74.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $8.4M | — | -10.3% |
| Capital Expenditures | $4.0M | — | +18.6% |
| Investing Cash Flow | -$4.0M | — | -18.6% |
| Financing Cash Flow | -$17.6M | — | -11.0% |
| Free Cash Flow | $4.4M | — | -26.3% |
| +1.9% |
| Stockholders' Equity | $530.1M | -2.2% | +2.5% |